{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:55:52Z","timestamp":1760608552794},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/cji.0b013e318155a11c","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T22:55:08Z","timestamp":1236120908000},"page":"817-824","source":"Crossref","is-referenced-by-count":12,"title":["Generation of EBV-specific T Cells for Adoptive Immunotherapy: A Novel Protocol Using Formalin-fixed Stimulator Cells to Increase Biosafety"],"prefix":"10.1097","volume":"30","author":[{"given":"Markus H.","family":"Hammer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Brestrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexa","family":"Mittenzweig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Roemhild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Zwinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carola","family":"Beier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Babel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Dieter","family":"Volk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Reinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-4-20210227","first-page":"2208","article-title":"Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study","volume":"94","author":"Curtis","year":"1999","journal-title":"Blood"},{"key":"R2-4-20210227","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549.417k32_1549_1555","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"R3-4-20210227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat Med"},{"key":"R4-4-20210227","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-4-20210227","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI0217214","article-title":"Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends","volume":"110","author":"Ho","year":"2002","journal-title":"J Clin Invest"},{"key":"R6-4-20210227","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1002\/eji.200526230","article-title":"HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy","volume":"35","author":"Hammer","year":"2005","journal-title":"Eur J Immunol"},{"key":"R7-4-20210227","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1535-6108(03)00113-2","article-title":"Adoptive immunotherapy: engineering T cell responses as biologic weapons for tumor mass destruction","volume":"3","author":"Ho","year":"2003","journal-title":"Cancer Cell"},{"key":"R8-4-20210227","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1182\/blood-2006-05-021782","article-title":"Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)","volume":"108","author":"Savoldo","year":"2006","journal-title":"Blood"},{"key":"R10-4-20210227","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood.V100.5.1755.h81702001755_1755_1764","article-title":"B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells","volume":"100","author":"Moosmann","year":"2002","journal-title":"Blood"},{"key":"R11-4-20210227","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"R14-4-20210227","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri1842","article-title":"Adoptive immunotherapy for cancer: building on success","volume":"6","author":"Gattinoni","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"R15-4-20210227","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1521-6926(04)00052-0","article-title":"Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation","volume":"17","author":"Locatelli","year":"2004","journal-title":"Best Pract Res Clin Haematol"},{"key":"R16-4-20210227","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0301-472X(02)00897-4","article-title":"Isolation and expansion of human cytomegalovirus-specific cytotoxic T lymphocytes using interferon-gamma secretion assay","volume":"30","author":"Bissinger","year":"2002","journal-title":"Exp Hematol"},{"key":"R17-4-20210227","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nm1001-1159","article-title":"Adoptive tumor therapy with T lymphocytes enriched through an IFN-gamma capture assay","volume":"7","author":"Becker","year":"2001","journal-title":"Nat Med"},{"key":"R18-4-20210227","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.168.2.909","article-title":"Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals","volume":"168","author":"Savoldo","year":"2002","journal-title":"J Immunol"},{"key":"R19-4-20210227","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/eji.200425936","article-title":"Selection of CMV-specific CD8+ and CD4+ T cells by mini-EBV-transformed B cell lines","volume":"35","author":"Wiesner","year":"2005","journal-title":"Eur J Immunol"},{"key":"R21-4-20210227","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/aid.1995.11.257","article-title":"Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects","volume":"11","author":"Lieberman","year":"1995","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R22-4-20210227","doi-asserted-by":"crossref","first-page":"7207","DOI":"10.1158\/1078-0432.CCR-04-1040","article-title":"In vitro stimulation with WT1 peptide-loaded Epstein-Barr virus-positive B cells elicits high frequencies of WT1 peptide-specific T cells with in vitro and in vivo tumoricidal activity","volume":"10","author":"Doubrovina","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R24-4-20210227","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002371-200305000-00008","article-title":"Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy","volume":"26","author":"Sili","year":"2003","journal-title":"J Immunother"},{"key":"R25-4-20210227","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1046\/j.1365-2567.1997.00253.x","article-title":"Enhancement of antigen-presenting ability of B lymphoma cells by partial inhibition of protein synthesis through inducing B7-1 expression","volume":"91","author":"Aoi","year":"1997","journal-title":"Immunology"},{"key":"R26-4-20210227","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0161-5890(99)00091-7","article-title":"Dynamics of molecules involved in antigen presentation: effects of fixation","volume":"36","author":"Barisas","year":"1999","journal-title":"Mol Immunol"},{"key":"R27-4-20210227","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00002371-200407000-00007","article-title":"Establishment and characterization of a bank of cytotoxic T lymphocytes for immunotherapy of Epstein-Barr virus-associated diseases","volume":"27","author":"Wilkie","year":"2004","journal-title":"J Immunother"}],"container-title":["Journal of Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CJI.0b013e318155a11c","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T20:01:47Z","timestamp":1621886507000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002371-200711000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/cji.0b013e318155a11c","relation":{},"ISSN":["1524-9557"],"issn-type":[{"value":"1524-9557","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}